Journal Logo

​​​​​Benefits for Authors

HemaSphere is an international open access journal. Distinct benefits and features of HemaSphere include:

  • 2022 Journal Impact Factor (preliminary): 6.6 (source: Clarivate Analytics. Final JIFs expected September/October, 2023.)
  • Open access and fully indexed in PubMed Central
  • Rigorous peer review guided by an expert Editorial Board
  • Fast publication
  • Low publication fees
  • Authors/funders retain copyright
  • Forum for publicly funded research
  • ​​EHA members can publish their work at a discounted rate for a limited period